{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:51:46Z","timestamp":1785909106527,"version":"3.56.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018896","name":"Sylvester Comprehensive Cancer Center","doi-asserted-by":"publisher","award":["P30CA240139"],"award-info":[{"award-number":["P30CA240139"]}],"id":[{"id":"10.13039\/100018896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018896","name":"Sylvester Comprehensive Cancer Center","doi-asserted-by":"publisher","award":["TSPA-2023-03"],"award-info":[{"award-number":["TSPA-2023-03"]}],"id":[{"id":"10.13039\/100018896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA268991"],"award-info":[{"award-number":["P01CA268991"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.redox.2026.104254","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:51:51Z","timestamp":1781020311000},"page":"104254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acidic bile salts induce APE1-dependent PRDX2 activation to drive oxaliplatin resistance via ferroptosis inhibition"],"prefix":"10.1016","volume":"95","author":[{"given":"Lei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Ballout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnapriya","family":"Thangaretnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi Steven","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver Gene","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zaika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Livingstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Shiekhattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunfa","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2101-6098","authenticated-orcid":false,"given":"Wael","family":"El-Rifai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1759-7714.14745","article-title":"Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040","volume":"14","author":"Liu","year":"2023","journal-title":"Thorac. Cancer"},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.redox.2026.104254_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10388-022-00927-4","article-title":"International trends in esophageal cancer incidence rates by histological subtype (1990\u20132012) and prediction of the rates to 2030","volume":"19","author":"Lin","year":"2022","journal-title":"Esophagus"},{"issue":"5","key":"10.1016\/j.redox.2026.104254_bib4","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.14309\/ajg.0000000000001121","article-title":"International trends in esophageal squamous cell carcinoma and adenocarcinoma incidence","volume":"116","author":"Rumgay","year":"2021","journal-title":"Off. J. Am. Coll. Gastroent. ACG"},{"issue":"suppl 1","key":"10.1016\/j.redox.2026.104254_bib5","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.2004.041517","article-title":"Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?","volume":"54","author":"Lagergren","year":"2005","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.redox.2026.104254_bib6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2017.07.046","article-title":"The epidemiology of esophageal adenocarcinoma","volume":"154","author":"Coleman","year":"2018","journal-title":"Gastroenterology"},{"issue":"5619","key":"10.1016\/j.redox.2026.104254_bib7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.1080405","article-title":"Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling","volume":"300","author":"Wood","year":"2003","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.redox.2026.104254_bib8","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1074\/jbc.R111.283432","article-title":"Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides","volume":"287","author":"Rhee","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.redox.2026.104254_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1089\/ars.2011.4260","article-title":"Protein glutathionylation in the regulation of peroxiredoxins: a family of thiol-specific peroxidases that function as antioxidants, molecular chaperones, and signal modulators","volume":"16","author":"Chae","year":"2012","journal-title":"Antioxid. Redox Signaling"},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev-biochem-060815-014431","article-title":"Multiple functions and regulation of mammalian peroxiredoxins","volume":"86","author":"Rhee","year":"2017","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.14348\/molcells.2016.2349","article-title":"The roles of peroxiredoxin and thioredoxin in hydrogen peroxide sensing and in signal transduction","volume":"39","author":"Netto","year":"2016","journal-title":"Mol. Cells"},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pro.3520","article-title":"Differential parameters between cytosolic 2\u2010Cys peroxiredoxins, PRDX1 and PRDX2","volume":"28","author":"Dalla Rizza","year":"2019","journal-title":"Protein Sci."},{"issue":"30","key":"10.1016\/j.redox.2026.104254_bib13","doi-asserted-by":"crossref","first-page":"11901","DOI":"10.1074\/jbc.RA117.001690","article-title":"Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxins","volume":"293","author":"Bolduc","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00054-0","article-title":"Interaction of tankyrase and peroxiredoxin II is indispensable for the survival of colorectal cancer cells","volume":"8","author":"Kang","year":"2017","journal-title":"Nat. Commun."},{"issue":"7040","key":"10.1016\/j.redox.2026.104254_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature03587","article-title":"Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II","volume":"435","author":"Choi","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nchembio.1695","article-title":"Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling","volume":"11","author":"Sobotta","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.redox.2026.104254_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101319","article-title":"PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer","volume":"28","author":"Wang","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104254_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11010-013-1891-4","article-title":"Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress","volume":"387","author":"Lu","year":"2014","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.21873\/cgp.20017","article-title":"Proteomics analysis of ovarian cancer cell lines and tissues reveals drug resistance-associated proteins","volume":"14","author":"Cruz","year":"2017","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.redox.2026.104254_bib20","first-page":"73","article-title":"The role of peroxiredoxin II in chemoresistance of breast cancer cells","author":"Wang","year":"2014","journal-title":"Breast Cancer"},{"issue":"5","key":"10.1016\/j.redox.2026.104254_bib21","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"cell"},{"issue":"2","key":"10.1016\/j.redox.2026.104254_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.redox.2026.104254_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.redox.2026.104254_bib24","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10637-021-01070-0","article-title":"System Xc\u2212: a key regulatory target of ferroptosis in cancer","volume":"39","author":"Liu","year":"2021","journal-title":"Invest. N. Drugs"},{"issue":"7","key":"10.1016\/j.redox.2026.104254_bib25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1158\/0008-5472.CAN-23-4042","article-title":"Exploring ferroptosis-inducing therapies for cancer treatment: challenges and opportunities","volume":"84","author":"Lei","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2026.104254_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fphys.2019.00139","article-title":"Mechanisms of ferroptosis and relations with regulated cell death: a review","volume":"10","author":"Lei","year":"2019","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.redox.2026.104254_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","article-title":"The multifaceted role of ferroptosis in liver disease","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Death Differ."},{"issue":"7545","key":"10.1016\/j.redox.2026.104254_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib29","article-title":"BAP1 suppresses tumor development by inducing ferroptosis upon SLC7A11 repression","volume":"6","author":"Zhang","year":"2019","journal-title":"Molecul. Cell. Oncol."},{"issue":"8","key":"10.1016\/j.redox.2026.104254_bib30","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","article-title":"The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11","volume":"79","author":"Liu","year":"2019","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.redox.2026.104254_bib31","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"7","key":"10.1016\/j.redox.2026.104254_bib32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2016.07.035","article-title":"Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer","volume":"381","author":"Roh","year":"2016","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.redox.2026.104254_bib35","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1158\/0008-5472.CAN-04-2490","article-title":"Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation","volume":"65","author":"Kimchi","year":"2005","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.redox.2026.104254_bib36","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1177\/0271678X20943823","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"40","author":"Percie du Sert","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.redox.2026.104254_bib37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/gutjnl-2022-327076","article-title":"Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-\u03baB activation in oesophageal adenocarcinoma","volume":"72","author":"Chen","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gutjnl-2023-329455","article-title":"Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma","volume":"73","author":"Lu","year":"2024","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.redox.2026.104254_bib39","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1593\/neo.06481","article-title":"Expression of calcium-binding proteins S100A2, S100A4 in Barrett's adenocarcinomas","volume":"8","author":"Lee","year":"2006","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/gut.2007.146290","article-title":"DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma","volume":"58","author":"Peng","year":"2009","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.redox.2026.104254_bib41","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/labinvest.2014.97","article-title":"Activin A balance regulates epithelial invasiveness and tumorigenesis","volume":"94","author":"Le Bras","year":"2014","journal-title":"Lab. Invest."},{"issue":"6","key":"10.1016\/j.redox.2026.104254_bib42","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1053\/j.gastro.2022.01.046","article-title":"Helicobacter pylori\u2013induced RASAL2 through activation of nuclear Factor-\u03baB promotes gastric tumorigenesis via \u03b2-catenin signaling Axis","volume":"162","author":"Cao","year":"2022","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.redox.2026.104254_bib43","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1158\/1078-0432.CCR-24-0027","article-title":"Targeting SMAD3 improves response to oxaliplatin in esophageal adenocarcinoma models by impeding DNA repair","volume":"30","author":"Ballout","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.redox.2026.104254_bib44","doi-asserted-by":"crossref","first-page":"16688","DOI":"10.18632\/oncotarget.7696","article-title":"APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts","volume":"7","author":"Hong","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.redox.2026.104254_bib45","doi-asserted-by":"crossref","first-page":"e4690","DOI":"10.21769\/BioProtoc.4690","article-title":"Cycloheximide (CHX) chase assay to examine protein half-life","volume":"13","author":"Miao","year":"2023","journal-title":"Bio Protoc."},{"key":"10.1016\/j.redox.2026.104254_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-1021-y","article-title":"Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage","volume":"38","author":"Zhou","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.redox.2026.104254_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015074","article-title":"Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome","volume":"5","author":"Kim","year":"2010","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.redox.2026.104254_bib48","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1158\/0008-5472.CAN-19-1166","article-title":"A comprehensive PDX gastric cancer collection captures cancer cell\u2013intrinsic transcriptional MSI traits","volume":"79","author":"Corso","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2026.104254_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2019.05.031","article-title":"NRF2 antioxidant response protects against acidic bile salts-induced oxidative stress and DNA damage in esophageal cells","volume":"458","author":"Peng","year":"2019","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.redox.2026.104254_bib50","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/gut.2006.103697","article-title":"Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus","volume":"56","author":"Dvorak","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.redox.2026.104254_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1261273","article-title":"OTUB1-mediated inhibition of ubiquitination: a growing list of effectors, multiplex mechanisms, and versatile functions","volume":"10","author":"Wu","year":"2024","journal-title":"Front. Mol. Biosci."},{"issue":"46","key":"10.1016\/j.redox.2026.104254_bib52","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1038\/s41388-018-0388-8","article-title":"Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR\u2013STAT3 signaling axis via induction of APE1","volume":"37","author":"Bhat","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.redox.2026.104254_bib53","series-title":"APE1\/Ref-1 Regulates STAT3 Transcriptional Activity and APE1\/Ref-1\u2013STAT3 dual-targeting Effectively Inhibits Pancreatic Cancer Cell Survival","author":"Cardoso","year":"2012"},{"issue":"3","key":"10.1016\/j.redox.2026.104254_bib54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/ars.2008.2194","article-title":"The many functions of APE1\/Ref-1: not only a DNA repair enzyme","volume":"11","author":"Tell","year":"2009","journal-title":"Antioxid. Redox Signaling"},{"issue":"21","key":"10.1016\/j.redox.2026.104254_bib55","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1007\/s00018-010-0486-4","article-title":"Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment","volume":"67","author":"Tell","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41698-017-0023-0","article-title":"Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic","volume":"1","author":"Shah","year":"2017","journal-title":"npj Precis. Oncol."},{"issue":"17","key":"10.1016\/j.redox.2026.104254_bib57","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1021\/bi400179m","article-title":"Inhibition of apurinic\/apyrimidinic endonuclease i's redox activity revisited","volume":"52","author":"Zhang","year":"2013","journal-title":"Biochemistry"},{"issue":"10466","key":"10.1016\/j.redox.2026.104254_bib58","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(24)02226-8","article-title":"Oesophageal cancer","volume":"404","author":"Yang","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2026.104254_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101970","article-title":"Activation of NRF2 by APE1\/REF1 is redox-dependent in Barrett's related esophageal adenocarcinoma cells","volume":"43","author":"Sriramajayam","year":"2021","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.redox.2026.104254_bib60","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00018-022-04131-6","article-title":"Molecular mechanisms associated with chemoresistance in esophageal cancer","volume":"79","author":"Lohan-Code\u00e7o","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.redox.2026.104254_bib61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/antiox8060169","article-title":"Role of cytosolic 2-Cys Prx1 and Prx2 in redox signaling","volume":"8","author":"Kim","year":"2019","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.redox.2026.104254_bib62","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/antiox13030298","article-title":"Antioxidant systems as modulators of ferroptosis: focus on transcription factors","volume":"13","author":"Punziano","year":"2024","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2013.05.046","article-title":"OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis","volume":"154","author":"Mevissen","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.redox.2026.104254_bib64","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/BJ20081318","article-title":"Structural basis and specificity of human otubain 1-mediated deubiquitination","volume":"418","author":"Edelmann","year":"2009","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.redox.2026.104254_bib65","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/ERC-18-0264","article-title":"Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer","volume":"26","author":"Saldana","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.redox.2026.104254_bib66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/antiox15020231","article-title":"Moonlighting functions of Mammalian peroxiredoxins in cellular signaling","volume":"15","author":"Kim","year":"2026","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2026.104254_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102194","article-title":"Redox regulation of DUBs and its therapeutic implications in cancer","volume":"48","author":"Tyagi","year":"2021","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.redox.2026.104254_bib68","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1021\/acschemneuro.1c00855","article-title":"S-nitrosylation of OTUB1 alters its stability and Ubc13 binding","volume":"13","author":"Kumari","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"5","key":"10.1016\/j.redox.2026.104254_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006203","article-title":"Unsolved mysteries: how does lipid peroxidation cause ferroptosis?","volume":"16","author":"Feng","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.redox.2026.104254_bib70","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine\u2013glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"eLife"},{"issue":"5","key":"10.1016\/j.redox.2026.104254_bib71","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","article-title":"Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles","volume":"16","author":"Eaton","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"15","key":"10.1016\/j.redox.2026.104254_bib72","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3390\/cells12151934","article-title":"A covalent inhibitor of Peroxiredoxin 2, reduces growth of glioblastoma cells by triggering ROS production","volume":"12","author":"Szeliga","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.redox.2026.104254_bib73","article-title":"Peroxiredoxins in colorectal neoplasms","author":"Wu","year":"2010","journal-title":"Histol. Histopathol."},{"issue":"17","key":"10.1016\/j.redox.2026.104254_bib74","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1158\/0008-5472.CAN-19-0237","article-title":"APE1 upregulates MMP-14 via redox-sensitive ARF6-mediated recycling to promote cell invasion of esophageal adenocarcinoma","volume":"79","author":"Lu","year":"2019","journal-title":"Cancer Res."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:36:38Z","timestamp":1785908198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726002533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":74,"alternative-id":["S2213231726002533"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104254","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acidic bile salts induce APE1-dependent PRDX2 activation to drive oxaliplatin resistance via ferroptosis inhibition","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104254"}}